These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24717837)

  • 41. Impact of Operative Time on Adverse Events Following Primary Total Joint Arthroplasty.
    Bohl DD; Ondeck NT; Darrith B; Hannon CP; Fillingham YA; Della Valle CJ
    J Arthroplasty; 2018 Jul; 33(7):2256-2262.e4. PubMed ID: 29551302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
    Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
    Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from a single institution.
    Lewis CG; Inneh IA; Schutzer SF; Grady-Benson J
    J Bone Joint Surg Am; 2014 Aug; 96(16):1327-32. PubMed ID: 25143492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing.
    Sindali K; Rose B; Soueid H; Jeer P; Saran D; Shrivastava R
    Eur J Orthop Surg Traumatol; 2013 May; 23(4):481-6. PubMed ID: 23412293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty--insights from the Multinational Global Orthopaedic Registry (GLORY).
    Friedman RJ; Gallus A; Gil-Garay E; FitzGerald G; Cushner F
    Am J Orthop (Belle Mead NJ); 2010 Sep; 39(9 Suppl):14-21. PubMed ID: 21290027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2).
    Barnes GD; Kaatz S; Golgotiu V; Gu X; Leidal A; Kobeissy A; Haymart B; Kline-Rogers E; Kozlowski J; Almany S; Leyden T; Froehlich JB
    J Thromb Thrombolysis; 2013 Jan; 35(1):10-4. PubMed ID: 22797905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty.
    Jaffer AK; Barsoum WK; Krebs V; Hurbanek JG; Morra N; Brotman DJ
    Mayo Clin Proc; 2005 Jun; 80(6):732-8. PubMed ID: 15945526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.
    Newman ET; Watters TS; Lewis JS; Jennings JM; Wellman SS; Attarian DE; Grant SA; Green CL; Vail TP; Bolognesi MP
    J Bone Joint Surg Am; 2014 Feb; 96(4):279-84. PubMed ID: 24553883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Anderson JL; Li J; Rodriguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple B; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2019 Sep; 322(9):834-842. PubMed ID: 31479138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Aspirin With Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty Compared With Other Anticoagulants: A Noninferiority Analysis.
    Hood BR; Cowen ME; Zheng HT; Hughes RE; Singal B; Hallstrom BR
    JAMA Surg; 2019 Jan; 154(1):65-72. PubMed ID: 30347089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.
    Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B;
    JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.
    Blin P; Samama CM; Sautet A; Benichou J; Lignot-Maleyran S; Lamarque S; Lorrain S; Lassalle R; Droz-Perroteau C; Mismetti P; Moore N
    Pharmacol Res; 2019 Mar; 141():201-207. PubMed ID: 30583081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.
    Anderson FA; Hirsh J; White K; Fitzgerald RH;
    Chest; 2003 Dec; 124(6 Suppl):349S-356S. PubMed ID: 14668417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.
    Liu J; Zhao J; Yan Y; Su J
    Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of Weight-Band Dosing of Tinzaparin for Venous Thromboembolism Prophylaxis on Persistent Wound Drainage in Adult Patients Undergoing Hip and Knee Arthroplasty.
    Cooper C; Antle O; Lowerison J; Dersch-Mills D; Kenny A
    Ann Pharmacother; 2022 Mar; 56(3):290-296. PubMed ID: 34130496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV-Positive Patients Are at Increased Risk of Venous Thromboembolism After Total Joint Replacement.
    Olson JJ; Schwab PE; Jackson J; Lange JK; Bedair HS; Abdeen A
    J Am Acad Orthop Surg; 2021 Jun; 29(11):479-485. PubMed ID: 33252548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
    Douketis JD; Eikelboom JW; Quinlan DJ; Willan AR; Crowther MA
    Arch Intern Med; 2002 Jul; 162(13):1465-71. PubMed ID: 12090882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complications of anticoagulation for thromboembolism in early postoperative total joint arthroplasty.
    Bloomfield MR; Patterson RW; Froimson MI
    Am J Orthop (Belle Mead NJ); 2011 Aug; 40(8):E148-51. PubMed ID: 22016874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review.
    Kwong LM; Kistler KD; Mills R; Wildgoose P; Klaskala W
    Expert Opin Pharmacother; 2012 Feb; 13(3):333-44. PubMed ID: 22220855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.